Tudorza Pressair (AstraZeneca Pharmaceuticals LP)


Welcome to the PulseAid listing for the Tudorza Pressair drug offered from AstraZeneca Pharmaceuticals LP. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AstraZeneca Pharmaceuticals LP
NON-PROPRIETARY NAME: aclidinium bromide
SUBSTANCE NAME: ACLIDINIUM BROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anticholinergic [EPC],Cholinergic Antagonists [MoA]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: INHALANT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-07-01
END MARKETING DATE: 0000-00-00


Tudorza Pressair HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTudorza Pressair from AstraZeneca Pharmaceuticals LP
LABELER NAME: AstraZeneca Pharmaceuticals LP
DEA SCHEDULE:
ACTIVE STRENGTH: 400(ug/1)
START MARKETING DATE: 2015-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0310-0800_b0423fc4-a73b-4542-9792-2e5fc54ae6ce
PRODUCT NDC: 0310-0800
APPLICATION NUMBER: NDA202450

Other ACLIDINIUM BROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AstraZeneca Pharmaceuticals LPTudorza Pressair
Forest Laboratories, Inc.Tudorza Pressair